10-K Decoder · All companies

NovoCure Limited

NVCR · FY2025 · Fiscal year ended Dec 31, 2025 · 10-K filed Feb 2026

Open the dashboardInfographicSummary

FY2025 key figures

$FY2025FY2024Change
Revenue$655M$605M+8.3%
Operating income−$154M−$170M+9.8%
Net income−$136M−$169M+19.2%

Latest quarter: Q3 2026

Form 10-Q · Three months ended Sep 30, 2026 · filed Oct 29, 2026

$Q3 2026Year earlierChange
Revenue$193M$167M+15.7%
Operating income−$6.20M−$36.0M+82.8%
Net income−$10.4M−$37.3M+72.1%

Q3 2026 dashboardQ3 2026 infographic

Questions

What was NovoCure's revenue in FY2025?
$655M in FY2025 (Fiscal year ended Dec 31, 2025), +8.3% vs $605M a year earlier, per its 10-K filed Feb 2026.
Was NovoCure profitable in FY2025?
No: net income was −$136M and operating income −$154M in FY2025.
What was NovoCure's revenue in Q3 2026?
$193M (+15.7% vs a year earlier), per its Form 10-Q filed Oct 29, 2026.